Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
for HIV Infections
Sites in Dallas +15 more locations
Sponsor: Gilead Sciences
Sex: All·Age: 18+
Code: NCT07682961·Phase 3·Recruiting·Listed Jul 2026